melanotan type 2 II | | 121062-08-6 Melanotan II - Indications, Uses,

Localized eye administration has proven effective with fewer systemic side effects (9)

Patients with NF1 possess only a single functional copy of the NF1 gene (e.g., the first hit), with loss of the second copy acting as an oncogenic second hit and thereby allowing constitutive activation of this pathway [9]

Despite both toxins ability to activate the inflammasome, TcdB induces activation more potently, even at much lower concentrations than TcdA [165]

doi: 10.1016/j.ceb.2007.09.014 247 XuCWangJZhuTShenYTangXFangLet al

2) , 152A Maggi, F., Vatteroni, M, Fornai, C, Morrica, A, Giorgi, M, Bendinelli, M., et al

Palatsi, R et al